Symbol:
Pik3c2g
Name:
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
RGD ID:
620231
Description:
Enables 1-phosphatidylinositol-3-kinase activity and 1-phosphatidylinositol-4-phosphate 3-kinase activity. Involved in phosphatidylinositol-3-phosphate biosynthetic process. Located in nuclear envelope. Human ortholog(s) of this gene implicated in type 2 diabetes mellitus. Orthologous to human PIK3C2G (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma); PARTICIPATES IN inositol phosphate metabolic pathway; phosphatidylinositol 3-kinase signaling pathway; INTERACTS WITH (+)-schisandrin B; 17beta-estradiol; 17beta-estradiol 3-benzoate.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LRRG00132; phosphatidylinositol 3-kinase C2 domain-containing subunit gamma; phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide; phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma; phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing gamma polypeptide; phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma; phosphoinositide 3-Kinase-C2-gamma; phosphoinositide-3-kinase, class 2, gamma polypeptide; PI3K-C2-gamma; PI3K-C2gamma; ptdIns-3-kinase C2 gamma; ptdIns-3-kinase C2 subunit gamma
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 4 174,215,527 - 174,583,378 (+) NCBI GRCr8 mRatBN7.2 4 172,483,752 - 172,851,623 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 4 172,484,345 - 172,850,544 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 4 178,779,339 - 179,145,536 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 4 174,563,498 - 174,929,713 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 4 173,184,038 - 173,550,261 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 4 173,732,196 - 174,102,502 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 4 173,732,248 - 174,102,496 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 4 237,973,381 - 238,271,814 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 4 238,344,297 - 238,356,116 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 176,712,201 - 177,074,095 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 4 176,957,324 - 177,319,218 (+) NCBI Celera 4 161,042,817 - 161,401,470 (+) NCBI Celera Cytogenetic Map 4 q44 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Pik3c2g Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PIK3C2G mRNA] CTD PMID:31150632 Pik3c2g Rat 1,2-dichloroethane increases expression ISO Pik3c2g (Mus musculus) 6480464 ethylene dichloride results in increased expression of PIK3C2G mRNA CTD PMID:28960355 Pik3c2g Rat 1,2-dimethylhydrazine affects expression ISO Pik3c2g (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of PIK3C2G mRNA CTD PMID:22206623 Pik3c2g Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PIK3C2G mRNA CTD PMID:32145629 Pik3c2g Rat 17beta-estradiol increases expression ISO Pik3c2g (Mus musculus) 6480464 Estradiol results in increased expression of PIK3C2G mRNA CTD PMID:39298647 Pik3c2g Rat 17beta-estradiol 3-benzoate increases methylation EXP 6480464 estradiol 3-benzoate results in increased methylation of PIK3C2G promoter CTD PMID:27415467 Pik3c2g Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PIK3C2G mRNA CTD PMID:22298810 and PMID:32109520 Pik3c2g Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PIK3C2G mRNA CTD PMID:18796159 more ... Pik3c2g Rat 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 Pik3c2g Rat 4,4'-sulfonyldiphenol affects methylation ISO PIK3C2G (Homo sapiens) 6480464 bisphenol S affects the methylation of PIK3C2G gene CTD PMID:31601247 Pik3c2g Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PIK3C2G mRNA CTD PMID:31881176 Pik3c2g Rat aflatoxin B1 affects expression ISO PIK3C2G (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of PIK3C2G protein CTD PMID:20106945 Pik3c2g Rat aflatoxin B1 decreases expression ISO PIK3C2G (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of PIK3C2G mRNA CTD PMID:22100608 and PMID:27153756 Pik3c2g Rat Aflatoxin B2 alpha increases methylation ISO PIK3C2G (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of PIK3C2G intron CTD PMID:30157460 Pik3c2g Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PIK3C2G mRNA CTD PMID:16483693 Pik3c2g Rat arsane affects methylation ISO PIK3C2G (Homo sapiens) 6480464 Arsenic affects the methylation of PIK3C2G gene CTD PMID:25304211 Pik3c2g Rat arsenic atom affects methylation ISO PIK3C2G (Homo sapiens) 6480464 Arsenic affects the methylation of PIK3C2G gene CTD PMID:25304211 Pik3c2g Rat atazanavir sulfate multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA CTD PMID:32152650 Pik3c2g Rat atazanavir sulfate decreases expression ISO PIK3C2G (Homo sapiens) 6480464 Atazanavir Sulfate results in decreased expression of PIK3C2G mRNA CTD PMID:32152650 Pik3c2g Rat benzo[a]pyrene increases methylation ISO PIK3C2G (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of PIK3C2G 5' UTR CTD PMID:27901495 Pik3c2g Rat benzo[a]pyrene decreases expression ISO PIK3C2G (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of PIK3C2G mRNA CTD PMID:32234424 Pik3c2g Rat Benzo[ghi]perylene increases expression ISO Pik3c2g (Mus musculus) 6480464 1 and 12-benzoperylene results in increased expression of PIK3C2G mRNA CTD PMID:26377693 Pik3c2g Rat bis(2-chloroethyl) sulfide decreases expression ISO Pik3c2g (Mus musculus) 6480464 Mustard Gas results in decreased expression of PIK3C2G mRNA CTD PMID:18955075 Pik3c2g Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PIK3C2G mRNA CTD PMID:25181051 Pik3c2g Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PIK3C2G mRNA CTD PMID:32145629 Pik3c2g Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PIK3C2G gene CTD PMID:28505145 Pik3c2g Rat bisphenol F decreases expression ISO Pik3c2g (Mus musculus) 6480464 bisphenol F results in decreased expression of PIK3C2G mRNA CTD PMID:38685157 Pik3c2g Rat cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of PIK3C2G mRNA CTD PMID:22110744 Pik3c2g Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PIK3C2G mRNA CTD PMID:25993096 Pik3c2g Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PIK3C2G mRNA CTD PMID:33453195 Pik3c2g Rat cantharidin increases expression ISO Pik3c2g (Mus musculus) 6480464 Cantharidin results in increased expression of PIK3C2G mRNA CTD PMID:36907384 Pik3c2g Rat CGP 52608 multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to PIK3C2G gene] CTD PMID:28238834 Pik3c2g Rat chenodeoxycholic acid multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA more ... CTD PMID:32152650 and PMID:33819548 Pik3c2g Rat chlorpyrifos decreases expression ISO Pik3c2g (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of PIK3C2G mRNA CTD PMID:34289071 Pik3c2g Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PIK3C2G mRNA CTD PMID:24386269 Pik3c2g Rat cyclosporin A decreases expression ISO PIK3C2G (Homo sapiens) 6480464 Cyclosporine results in decreased expression of PIK3C2G mRNA CTD PMID:20106945 Pik3c2g Rat cyclosporin A multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA CTD PMID:32152650 Pik3c2g Rat cyclosporin A increases expression ISO PIK3C2G (Homo sapiens) 6480464 Cyclosporine results in increased expression of PIK3C2G mRNA CTD PMID:27989131 Pik3c2g Rat decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of PIK3C2G mRNA CTD PMID:23640034 Pik3c2g Rat deoxycholic acid multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA more ... CTD PMID:32152650 and PMID:33819548 Pik3c2g Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PIK3C2G mRNA CTD PMID:29391264 Pik3c2g Rat epoxiconazole affects expression ISO Pik3c2g (Mus musculus) 6480464 epoxiconazole affects the expression of PIK3C2G mRNA CTD PMID:35436446 Pik3c2g Rat ethanol increases expression EXP 6480464 Ethanol results in increased expression of PIK3C2G mRNA CTD PMID:15353170 Pik3c2g Rat fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of PIK3C2G mRNA CTD PMID:16707586 Pik3c2g Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PIK3C2G mRNA CTD PMID:24136188 Pik3c2g Rat fructose multiple interactions EXP 6480464 [Fructose co-treated with Oleanolic Acid] results in increased expression of PIK3C2G mRNA CTD PMID:24704288 Pik3c2g Rat glycochenodeoxycholic acid multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA more ... CTD PMID:32152650 and PMID:33819548 Pik3c2g Rat glycocholic acid multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA more ... CTD PMID:32152650 and PMID:33819548 Pik3c2g Rat glycodeoxycholic acid multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA more ... CTD PMID:32152650 and PMID:33819548 Pik3c2g Rat isotretinoin decreases expression ISO PIK3C2G (Homo sapiens) 6480464 Isotretinoin results in decreased expression of PIK3C2G mRNA CTD PMID:20436886 Pik3c2g Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of PIK3C2G gene CTD PMID:35440735 Pik3c2g Rat mono(2-ethylhexyl) phthalate decreases expression ISO Pik3c2g (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of PIK3C2G mRNA CTD PMID:22401849 Pik3c2g Rat N-Nitrosopyrrolidine decreases expression ISO PIK3C2G (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of PIK3C2G mRNA CTD PMID:32234424 Pik3c2g Rat nefazodone decreases expression ISO PIK3C2G (Homo sapiens) 6480464 nefazodone results in decreased expression of PIK3C2G mRNA CTD PMID:32152650 Pik3c2g Rat nefazodone multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA CTD PMID:32152650 Pik3c2g Rat nickel atom decreases expression ISO PIK3C2G (Homo sapiens) 6480464 Nickel results in decreased expression of PIK3C2G mRNA CTD PMID:24768652 and PMID:25583101 Pik3c2g Rat nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of PIK3C2G mRNA CTD PMID:22110744 Pik3c2g Rat O-methyleugenol decreases expression ISO PIK3C2G (Homo sapiens) 6480464 methyleugenol results in decreased expression of PIK3C2G mRNA CTD PMID:32234424 Pik3c2g Rat oleanolic acid multiple interactions EXP 6480464 [Fructose co-treated with Oleanolic Acid] results in increased expression of PIK3C2G mRNA CTD PMID:24704288 Pik3c2g Rat paracetamol affects expression ISO Pik3c2g (Mus musculus) 6480464 Acetaminophen affects the expression of PIK3C2G mRNA CTD PMID:17562736 Pik3c2g Rat paracetamol multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of PIK3C2G mRNA CTD PMID:33819548 Pik3c2g Rat paracetamol decreases expression ISO PIK3C2G (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PIK3C2G mRNA CTD PMID:29067470 Pik3c2g Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PIK3C2G mRNA CTD PMID:32680482 Pik3c2g Rat perfluorononanoic acid decreases expression ISO PIK3C2G (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of PIK3C2G mRNA CTD PMID:32588087 Pik3c2g Rat perfluorooctane-1-sulfonic acid decreases expression ISO PIK3C2G (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of PIK3C2G mRNA CTD PMID:27153767 Pik3c2g Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PIK3C2G mRNA CTD PMID:16221955 and PMID:19162173 Pik3c2g Rat pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PIK3C2G mRNA CTD PMID:16707586 Pik3c2g Rat pirinixic acid increases expression ISO Pik3c2g (Mus musculus) 6480464 pirinixic acid results in increased expression of PIK3C2G mRNA CTD PMID:23811191 Pik3c2g Rat pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PIK3C2G mRNA CTD PMID:19162173 and PMID:22484513 Pik3c2g Rat pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of PIK3C2G mRNA CTD PMID:19162173 Pik3c2g Rat pregnenolone 16alpha-carbonitrile increases expression ISO Pik3c2g (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of PIK3C2G mRNA CTD PMID:28903501 Pik3c2g Rat sodium arsenite decreases expression ISO Pik3c2g (Mus musculus) 6480464 sodium arsenite results in decreased expression of PIK3C2G mRNA CTD PMID:36209798 and PMID:37682722 Pik3c2g Rat sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of PIK3C2G mRNA CTD PMID:22110744 Pik3c2g Rat sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of PIK3C2G mRNA CTD PMID:25993096 Pik3c2g Rat tartrazine multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PIK3C2G mRNA CTD PMID:33819548 Pik3c2g Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PIK3C2G mRNA CTD PMID:31150632 Pik3c2g Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PIK3C2G mRNA] CTD PMID:31150632 Pik3c2g Rat tetracycline increases expression ISO Pik3c2g (Mus musculus) 6480464 Tetracycline results in increased expression of PIK3C2G mRNA CTD PMID:16917069 Pik3c2g Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PIK3C2G mRNA CTD PMID:23411599 and PMID:34492290 Pik3c2g Rat tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of PIK3C2G mRNA CTD PMID:16403772 Pik3c2g Rat titanium dioxide increases expression ISO Pik3c2g (Mus musculus) 6480464 titanium dioxide results in increased expression of PIK3C2G mRNA CTD PMID:35295148 Pik3c2g Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PIK3C2G mRNA CTD PMID:33387578 Pik3c2g Rat triclosan multiple interactions ISO PIK3C2G (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of PIK3C2G mRNA CTD PMID:33819548 Pik3c2g Rat triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of PIK3C2G mRNA CTD PMID:30589522 Pik3c2g Rat valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of PIK3C2G mRNA CTD PMID:24136188 Pik3c2g Rat valproic acid decreases methylation ISO PIK3C2G (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of PIK3C2G gene CTD PMID:29154799 Pik3c2g Rat valproic acid decreases expression ISO PIK3C2G (Homo sapiens) 6480464 Valproic Acid results in decreased expression of PIK3C2G mRNA CTD PMID:29154799
Imported Annotations - KEGG (archival)
(+)-schisandrin B (EXP) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP,ISO) 17beta-estradiol 3-benzoate (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP) 3,3',4,4',5-pentachlorobiphenyl (EXP) 4,4'-sulfonyldiphenol (ISO) acetamide (EXP) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) ammonium chloride (EXP) arsane (ISO) arsenic atom (ISO) atazanavir sulfate (ISO) benzo[a]pyrene (ISO) Benzo[ghi]perylene (ISO) bis(2-chloroethyl) sulfide (ISO) bisphenol A (EXP) bisphenol F (ISO) cadmium dichloride (EXP) cantharidin (ISO) CGP 52608 (ISO) chenodeoxycholic acid (ISO) chlorpyrifos (ISO) cobalt dichloride (EXP) cyclosporin A (ISO) decabromodiphenyl ether (EXP) deoxycholic acid (ISO) endosulfan (EXP) epoxiconazole (ISO) ethanol (EXP) fenofibrate (EXP) flutamide (EXP) fructose (EXP) glycochenodeoxycholic acid (ISO) glycocholic acid (ISO) glycodeoxycholic acid (ISO) isotretinoin (ISO) methoxychlor (EXP) mono(2-ethylhexyl) phthalate (ISO) N-Nitrosopyrrolidine (ISO) nefazodone (ISO) nickel atom (ISO) nickel dichloride (EXP) O-methyleugenol (ISO) oleanolic acid (EXP) paracetamol (ISO) paraquat (EXP) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP) pirinixic acid (EXP,ISO) pregnenolone 16alpha-carbonitrile (EXP,ISO) sodium arsenite (ISO) sodium dichromate (EXP) tartrazine (ISO) tetrachloromethane (EXP) tetracycline (ISO) thioacetamide (EXP) tipifarnib (EXP) titanium dioxide (ISO) trichloroethene (EXP) triclosan (ISO) triphenyl phosphate (EXP) valdecoxib (EXP) valproic acid (ISO)
Pik3c2g (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 4 174,215,527 - 174,583,378 (+) NCBI GRCr8 mRatBN7.2 4 172,483,752 - 172,851,623 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 4 172,484,345 - 172,850,544 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 4 178,779,339 - 179,145,536 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 4 174,563,498 - 174,929,713 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 4 173,184,038 - 173,550,261 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 4 173,732,196 - 174,102,502 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 4 173,732,248 - 174,102,496 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 4 237,973,381 - 238,271,814 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 4 238,344,297 - 238,356,116 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 176,712,201 - 177,074,095 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 4 176,957,324 - 177,319,218 (+) NCBI Celera 4 161,042,817 - 161,401,470 (+) NCBI Celera Cytogenetic Map 4 q44 NCBI
PIK3C2G (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 18,242,961 - 18,726,817 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 18,242,961 - 18,648,416 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 18,414,452 - 18,801,350 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 18,305,741 - 18,692,617 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 12 18,305,740 - 18,692,615 NCBI Celera 12 23,559,670 - 23,946,872 (+) NCBI Celera Cytogenetic Map 12 p12.3 NCBI HuRef 12 18,182,567 - 18,569,771 (+) NCBI HuRef CHM1_1 12 18,379,684 - 18,766,393 (+) NCBI CHM1_1 T2T-CHM13v2.0 12 18,118,895 - 18,602,723 (+) NCBI T2T-CHM13v2.0
Pik3c2g (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 6 139,591,070 - 139,915,010 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 6 139,564,219 - 139,915,010 (+) Ensembl GRCm39 Ensembl GRCm38 6 139,614,072 - 139,969,284 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 6 139,587,221 - 139,969,284 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 6 139,664,380 - 139,917,805 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv37 6 139,562,593 - 139,605,759 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 6 139,678,267 - 139,931,692 (+) NCBI MGSCv36 mm8 Celera 6 142,714,228 - 143,033,452 (+) NCBI Celera Cytogenetic Map 6 G2 NCBI cM Map 6 69.7 NCBI
Pik3c2g (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955413 14,454,377 - 14,764,558 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955413 14,454,376 - 14,764,323 (+) NCBI ChiLan1.0 ChiLan1.0
PIK3C2G (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 10 23,702,676 - 24,088,671 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 12 23,699,436 - 24,085,421 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 12 18,258,487 - 18,644,464 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 12 18,664,539 - 19,030,778 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 12 18,664,631 - 19,030,493 (+) Ensembl panpan1.1 panPan2
PIK3C2G (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 27 28,446,629 - 28,818,198 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 27 28,424,899 - 28,796,902 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 27 17,634,256 - 18,004,900 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 27 28,777,707 - 29,148,879 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 27 28,777,942 - 29,120,607 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 27 28,624,760 - 28,982,990 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 27 28,617,093 - 28,982,011 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 27 17,346,838 - 17,712,725 (+) NCBI UU_Cfam_GSD_1.0
Pik3c2g (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404945 89,681,373 - 90,001,143 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936548 7,604,404 - 7,856,872 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936548 7,604,272 - 7,923,984 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
PIK3C2G (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 5 54,474,622 - 54,849,512 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 5 54,474,623 - 54,849,520 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 5 57,747,735 - 58,146,257 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
PIK3C2G (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 11 18,099,328 - 18,500,030 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 11 18,118,717 - 18,499,985 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666069 16,715,340 - 17,100,145 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Pik3c2g (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 16 Count of miRNA genes: 15 Interacting mature miRNAs: 16 Transcripts: ENSRNOT00000041499 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
6478754 Anxrr43 Anxiety related response QTL 43 0.14035 locomotor behavior trait (VT:0001392) distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493) 4 144639524 182687754 Rat 1576316 Ept5 Estrogen-induced pituitary tumorigenesis QTL 5 3.8 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 4 83428419 177635233 Rat 2303623 Vencon2 Ventilatory control QTL 2 3.8 respiration trait (VT:0001943) minute ventilation (CMO:0000132) 4 135204660 180204660 Rat 724558 Plsm2 Polydactyly-luxate syndrome (PLS) morphotypes QTL 2 0.0003 hindlimb integrity trait (VT:0010563) hind foot phalanges count (CMO:0001949) 4 132422778 177422778 Rat 6478693 Anxrr32 Anxiety related response QTL 32 0.00092 locomotor behavior trait (VT:0001392) measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957) 4 144639524 182687754 Rat 1578674 Bmd12 Bone mineral density QTL 12 3.8 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 4 135699135 180699135 Rat 1331738 Bp209 Blood pressure QTL 209 2.979 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 4 138503169 179293946 Rat 6478700 Anxrr33 Anxiety related response QTL 33 0.00896 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 4 144639524 182687754 Rat 1298524 Oia8 Oil induced arthritis QTL 8 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 4 138503169 173369699 Rat 634342 Cia24 Collagen induced arthritis QTL 24 4.5 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 4 146565735 175236377 Rat 10053718 Scort25 Serum corticosterone level QTL 25 2.15 0.0097 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 4 155561574 182687754 Rat 61362 Oia2 Oil induced arthritis QTL 2 0.001 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 4 138503169 173369699 Rat 1549827 Scl46 Serum cholesterol level QTL 46 3.5 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 4 132396220 177396220 Rat 2293659 Bmd35 Bone mineral density QTL 35 4.5 0.0001 femur strength trait (VT:0010010) femoral neck ultimate force (CMO:0001703) 4 137755016 181392681 Rat 10401796 Kidm48 Kidney mass QTL 48 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 4 145568712 182687754 Rat 6478718 Anxrr34 Anxiety related response QTL 34 0.00896 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 4 144639524 182687754 Rat 2316958 Gluco58 Glucose level QTL 58 10 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 4 11320076 180699135 Rat 6478748 Anxrr42 Anxiety related response QTL 42 0.28008 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 4 144639524 182687754 Rat 1300109 Rf13 Renal function QTL 13 3.91 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 4 157710145 182687754 Rat
D4Got275
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 4 174,405,942 - 174,406,184 (+) Marker Load Pipeline mRatBN7.2 4 172,674,773 - 172,675,015 (+) MAPPER mRatBN7.2 Rnor_6.0 4 173,928,221 - 173,928,462 NCBI Rnor6.0 Rnor_5.0 4 238,164,878 - 238,165,119 UniSTS Rnor5.0 RGSC_v3.4 4 176,903,911 - 176,904,152 UniSTS RGSC3.4 Celera 4 161,228,714 - 161,228,955 UniSTS Cytogenetic Map 4 q44 UniSTS
BE113549
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 172,486,558 - 172,486,715 (+) MAPPER mRatBN7.2 Rnor_6.0 4 173,734,462 - 173,734,618 NCBI Rnor6.0 Rnor_5.0 4 237,975,595 - 237,975,751 UniSTS Rnor5.0 RGSC_v3.4 4 176,714,415 - 176,714,571 UniSTS RGSC3.4 Celera 4 161,045,031 - 161,045,187 UniSTS RH 3.4 Map 4 1031.7 UniSTS Cytogenetic Map 4 q44 UniSTS
RH137861
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 172,522,615 - 172,522,754 (+) MAPPER mRatBN7.2 Rnor_6.0 4 173,770,513 - 173,770,651 NCBI Rnor6.0 Rnor_5.0 4 238,011,653 - 238,011,791 UniSTS Rnor5.0 RGSC_v3.4 4 176,750,473 - 176,750,611 UniSTS RGSC3.4 Celera 4 161,081,066 - 161,081,204 UniSTS RH 3.4 Map 4 1033.6 UniSTS Cytogenetic Map 4 q44 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
10
39
92
86
90
59
25
59
6
196
81
77
39
58
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000041499 ⟹ ENSRNOP00000043855
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 4 172,484,345 - 172,850,544 (+) Ensembl Rnor_6.0 Ensembl 4 173,732,248 - 174,102,496 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000078963 ⟹ ENSRNOP00000071128
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 4 172,722,676 - 172,737,935 (+) Ensembl
RefSeq Acc Id:
NM_053923 ⟹ NP_446375
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 4 174,215,527 - 174,581,708 (+) NCBI mRatBN7.2 4 172,484,345 - 172,850,547 (+) NCBI Rnor_6.0 4 173,732,248 - 174,102,499 (+) NCBI Rnor_5.0 4 237,973,381 - 238,271,814 (+) NCBI Rnor_5.0 4 238,344,297 - 238,356,116 (+) NCBI RGSC_v3.4 4 176,712,201 - 177,074,095 (+) RGD Celera 4 161,042,817 - 161,401,470 (+) RGD
Sequence:
GAGGAAGCAAAGACCGGGCAAAACACATGAAGGAAAATTTGGAACTTCTTTTATAATATCAACAAGACATTTGGGGCCAAATAAATCCTCTCCGTTACACAAAACCAAAAATGGCATACAATTGGCAA ACAGAGCCAAACCGTGCTGAACCACAGGAAGGTGGACATGATCACCAGCAGTGTCACCATGCAGACCAGCACCTTTCTTCCAGGCAAGTCAGGTTGGGTTTTGATCAGCTTGTGGAAGAGCTCAGTAA CAAAACTCCACTGCCTGAGGATGAAAAAGAAGGCACGTGTTTTGTACCAGATACACCAAACTTGGATTCAAAATGGCAATCCATATATGGACCCCACCCAAGGCACTTCAATGAATTCACTTCTCAGA GTCCCCACTTCTCCCAGCTTCCTTTTGGAAAAGCATCAGCCATTGGTTTTAATCCTGCTGTATTACCTGCACATCAGTTCATTCATGAGGGAGCCTCCTGGAGAAATCCCACAAGAAAATATCATGGT GGTGAGGATCCCAGGTTCAGTGCTCTAACTCCGTCATCCACTGGCTTGGATAAATGTCATCAACAAGGACAATCAGGGACCGAACATTGTAACTATTATGTGGAACCTGAAAACAATGTTCCCCATCA TTATTCACCCTACTCAATGGACTCCATACCCGATAGTGAGGAAAAAGGAAGTGGAGATGCGGATCTTGTAGAACCTTCTCTGGTGTTCTCTAAAGACTCCTTTCTACCCAGGGCATCGGAGAACATGT CAGTGGAAAGCACAGAGCCCATTGGTTGCCCCCTTGAAATAGTTGAAGCACCCCAAGGGAGTAACAAGAGCCTCGCCTCCTTTTGCAACAATGTAACAAAAATAAGAGGACTATATCATGCAAGTGAC ACTAATTCCAATTCCGGAAAGATCTGGGCCATCACCACAGCCTATCCATCTCGGCTCTTCGCTGACACCCAGTTCAGAGTTAAAATTTCCACTGATAACTCGGCACAACTTCTTCTTCTTAAGCCACC CGCTAATTATCTTGTCAAAGACCTAATTGCCGAAATTCTACTTTTATGTGCAAATGAGCAGCTTTCCCCCAAAGAGTATCTTCTAAGTATATGCGGTTCTGAGGAATTTTTACAGACGGATCACTGTC TAGGGAGCCACAAAATATTTCAGAAAAGTAAATCTGTCATTCAACTCCATCTCCAGAGAAGCAGGGACACTCCAGGAAAATTATCCCGGAAGAGGGATGATGACCGCAGTCGGGTCCATCTGAACCAA CTTCTAGAATTTACACATATTTGGAAAATATCCAGACAATGCCTCTCCACAGTAATGAAAAGCTACAACCTCCATGTCGAGCACCTGTTGAAAACCCAGGAAGATGTGGAGGAGAAACCTCTGTCATC CATGTTTTCCTGTGGCCGACACCCTCCTCAGCCACATGGGAATGACATTATTGAAGATGTTAGAAACATATGCAGTGTTCTGGGGTGTATTGAAACCAAACAAGTTTCAGATGCAGTAAAAGAACTAA CTCTAATTCTGCAGAGACCATCACAGAATTTTCATCAGAATTCAGAGACTTCAAAAAAAGGCTTCATAGAGAACGTGACATCGGAACTGTCGAGGTCCCTCCATCAGCTGGTTGACGTGTACTGCAGT AGCTTTTGTACAGATTTCCGGCCTGCGCGCGCACCTGGAGGCGTCTCCCGCGACCACGCTGGGCTCCACTCCCACCTGAGCTTCACGGTGTGTTCCCTGCACAATGTTCCAGAAACTTGGGCACACAG CTACAAAGCATTTTCATTTTCCTGCTGGCTCACATATGCTGGGAAGAAGCTGTGCCAAGTGAAAAGCTGCAGATCCCTGCCAGTCACAAAGTCATTCTCTTTTTCGGTGAACTGGAATGAAATAATCA ATTTTCCTCTTGAGATAAAGTCACTTCCAAGAGAATCCATGCTCGTTATAAAGCTGTTTGGGATTGACAGTGCCACCCACAGCGCAAATCTGCTGGCCTGGACCTGCCTTCCACTATTTCCAAAAGAA AAGTCTCCGCTGGGGTCTAGGCTTCTCAGCATGACACTACAGAGTGAGCCTCCTATAGAAATGATGGCTCCAGGAGTATGGGATGGGAGCCAGCCTACCCCACTGACCCTGCAGATAGATTTTCCAGC TGCCACGTGGGAGTACGTGAAACCTGAGACTGAAGAGAACAGAACTGACCACCAAGAGCCTCCAAGAGAGTGTTTAAAACACATCGCCAGACTCTCCCAAAAGCAGCCTCCCTTGCTACTTTCTGTGG AAAAGAGGAGATATTTGTGGTTTTATCGTTTCTACTGCAACAATGAGAACTCCTCTCTCCCTCTGGTCTTGGGCAGCGCCCCTGGTTGGGATGAAGGGACAGTTTCGGAAATGCATGCCGTCTTGAGA AGGTGGACATTTTCCCATCCGTTGGAAGCTCTTGGCCTTTTGACTTCCAGGTTTCCAGACCAAGACATTCGTGAAGTTGCCGTTCAACAGTTAGACAACTTCTTGACCGATGAGCTGCTGGACTGCCT CCCACAGCTAGTTCAGGCTGTCAAGTTTGAGTGGAGTCTCGAAAGTCCCTTGGTGGAACTCCTGCTTCATCGATCCTTGCAAAGCATCCGAGTGGCTCACCGCCTGTTCTGGCTGCTGCGGGATGCAC AAGGTGAAGACTACTTTAAAAGCTGGTACCAGGAGCTTTTGGCCGCTCTCCAGTTCTGTGCAGGAGAAGCCCTGATCGAAGAGCTTTCCAAAGAGCAGAAACTTGTCAAACTCCTGGGTGATATTGGA GAAAAAGTGAAGTCGGCTGGCGATGCTCAGAGAAAGGATGTGCTAAAGAAGGAGATTGGCAGTCTAGAAGAATTCTTTAAAGATATAAAGACTTGCCATCTTCCTCTGAACCCGGCCCTGTGCGTAAA AGGAATTGATCGGGATGCATGTTCATATTTCACATCTAATGCCTTGCCATTGAAGATCACTTTCATCAATGCTAATCCAATGGGCAAAAATATCAGTGTTATTTTTAAGGCCGGCGACGATCTTCGGC AGGATATGCTTGTTCTGCAGATTATTCAAGTGATGGACAACGTTTGGCTTCAGGAGGGCCTCGATATGCAAATGATCATTTATGGATGTCTAGCCACAGGAAAGGCTCAAGGATTCATAGAGATGGTG CCTGATGCTGTAACGCTTGCCAAGATCCATCTGCACTCTGGGCTGATAGGACCCCTGAAAGAAAACACCATCAAGAAGTGGTTCAGTCAGCACAACCACTTAAAGGAAGATTATGAAAAGGCCTTGAG GAACTTTTTTTACTCTTGTGCTGGCTGGTGTGTGGTGACATTCATCTTGGGAGTCTGTGACCGACATAATGACAATATCATGCTGACAAAGTCAGGCCACATGTTTCATATTGACTTTGGAAAATTCT TGGGTCACGCACAAACATTTGGCGGTATAAAAAGGGACCGAGCGCCTTTCATTTTTACTTCAGAGATGGAGTACTTTATTACGGAGGGTGGGAAAAACACACAGCATTTTCAAGACTTCGTGGAACTC TGCTGCAGAGCCTACAACATTGTGAGGAAGCACAGCCAACTGCTCCTGAGCCTTCTAGAAATGATGCTGCATGCCGGGCTTCCTGAGCTGAGGGGGATTGAAGACCTGAAATACGTACACGACAATCT CCGGCCACAAGACACAGACCTGGAAGCCACAAGTCATTTTACCACGAAGATAAAGCAGAGTCTGGAGTGCTTCCCAGTTAAACTGAATAACCTGATCCACACGCTTGCACAGATGCCAGCCTTCAGCC TTGCCAGACCTGCCCCTCAGACTCCTCCCCAGGAGTGCTGCGTCCTGAATAAAACCAGGACAATTCAGAGAGTCACAATTTTAGGGTTCAGCAAGACACACAGCAACCTGTACCTGATCGAGGTGACA CGCAGCGACAACAGGAAAAACCTGGCCAAAAAGTCCTTCGAGCAGTTTTACAGACTTCACAGCCAGATTCAGAAGCAGTTCCCCTTGTTGACTCTCCCAGAGTTTCCTCACTGGTGGCATCTACCTTT CACAGACTCGCACCATGAGAGAATCCGAGATCTGAGTCACTACGTGGAACAGGTGCTGCACGGATCTTACGAAGTCGCAAACAGTGATTGTGTACTCAGTTTTTTTCTCTCTGAACATATACAACAGA CCCTTGAAGACTCTCCATTTGTGGACCCAGGTGACCATTCTCCAGACAAGAGCCCCCAGGTGCAGTTGCTGATGACCTATGAGGACACAAAGCTCACCATCCTAGTGAAACACTTGAAAAACATCCAT CTCCCAGATGGCTCAGCGCCCAGCGCACATGTTGAAATTTATCTTCTGCCACATCCCAGTGAAGTTCGCAGGAAGAAAACAAAGTGCGTTCCAAAATGCACTGACCCAACTTACAATGAAATTGTGGT ATATGATGACGTCTCAGGACTTCAGGGACATGTTTTAATGCTCATTGTGAAGAGCAAAACTGTATTTGTGGGAGCGGTTAACATTCAGCTCTGCAGTGTTCCCCTCAATGAAGAAAAGTGGTACCCAT TAGGGAACAGTATCATCTGACCAATGCCATGAATGTATGCATTATTGATTAAGTACTTGTGTGTTTTCAGCTTCCATTTCCCCTATAGCATACACAAGGCATCTTTCTTGCGGAAGATGGCTTGGAGC AGTGGTTCTCACTCAGCGTCCCTAACACTGCGACCCTTTAATACAATTCCTGGTGATTGTAGTGACCCAAACCACAAAATTATTTTAGTTGCTATTTCACAACTGTAATTTTGACACGGTTATGAATT GCAATGTATATATCTGATCTACAGGATACCTACTATTCGACCCCTGTGATAAAAGGGTCATTGGACAATCCCAAAGGGTCATGACTCATGGGTTGAGAACCACAGGCTTAGAGTGGTCACAGAAGAAG CAGATCAAAATCAGTCTTTTGTAGCTCTTTCTTCTCTACCTTCTCCTTATTTTCTTATCATATTTTCTCCTTGGAATATTCATCATGGAAAATCCCATATGCAAAGTCATGAAAGAATGATTCATTTA ATATGCATTTTTGAATCAAACTAAGTTCATGTCTTGCCTTAATTGCTTGTTGAGGTCAAAATTATACTTTTAGGGTGTTTTCTAAAGCTAGGAGAAGCTCATGTAAGGGTTAAGAATATTTGCAATAT ATTTCAAAAGTTAAATATGTGTACAAGCCACATATCTAGTCATGATTGAATTTATTGAGAGAATTGGTGATCTCCAACCATGTGCTATAATTTTTCTATCAAAAAAAAATCCCTAAGATTTTTCTATT GCATAGATTTTTTTTCTTTAAGAATTTCATGCATGTATATAGTGCTTTCGTTATTGTAGCTTCTCTCTTTTTTAGTTGTCCCCACACCCATCAACAACTGTTCTTCTCTAAAACTCCTGTATTCCTGT GGGGAGTTTTATTTTTAAGATGGGCATCAAACTATATATCCCAGCTGACCTAGAGCTTGCTATGTTGACCAGGTGGGCCCCAAATCACAGTGGTCCTCCTGCCTCTGTTTCCCGACCGCTAAGGTTCC AGGTCATTGGATCTTGTCTGTAATTTTTAAGTTCAGTTCTTAGAATTTGATATTGATCAATCCAGTGTCATTGTGTCTTCCAGCCTCGGTCATGTTCACACCTTAAATCTTATTAATCTCCAAACCCA AAATATCCAACTTTTAAGTTCACCATTTAAAACGCCTCTTTGCGTGTTAAATACTCTCACTGCACTTGAACCAACACCTTGTGTTCGCACGGACCAGATAGATGATCTCACAGTTTGTCACCTGTGTA ACAGGCAAACCCAGAGGACGCCTCCAAGATAATCAAACTGGAGGTTTCAAAAATAAAACATCTGCCATAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_039106948 ⟹ XP_038962876
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 4 174,252,810 - 174,583,378 (+) NCBI mRatBN7.2 4 172,483,758 - 172,851,623 (+) NCBI
RefSeq Acc Id:
XR_005503143
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 4 174,252,810 - 174,371,605 (+) NCBI mRatBN7.2 4 172,483,752 - 172,640,505 (+) NCBI
RefSeq Acc Id:
XR_010065609
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 4 174,252,810 - 174,371,677 (+) NCBI
RefSeq Acc Id:
NP_446375 ⟸ NM_053923
- UniProtKB:
O70173 (UniProtKB/Swiss-Prot), D3ZE56 (UniProtKB/TrEMBL)
- Sequence:
MAYNWQTEPNRAEPQEGGHDHQQCHHADQHLSSRQVRLGFDQLVEELSNKTPLPEDEKEGTCFVPDTPNLDSKWQSIYGPHPRHFNEFTSQSPHFSQLPFGKASAIGFNPAVLPAHQFIHEGASWRNP TRKYHGGEDPRFSALTPSSTGLDKCHQQGQSGTEHCNYYVEPENNVPHHYSPYSMDSIPDSEEKGSGDADLVEPSLVFSKDSFLPRASENMSVESTEPIGCPLEIVEAPQGSNKSLASFCNNVTKIRG LYHASDTNSNSGKIWAITTAYPSRLFADTQFRVKISTDNSAQLLLLKPPANYLVKDLIAEILLLCANEQLSPKEYLLSICGSEEFLQTDHCLGSHKIFQKSKSVIQLHLQRSRDTPGKLSRKRDDDRS RVHLNQLLEFTHIWKISRQCLSTVMKSYNLHVEHLLKTQEDVEEKPLSSMFSCGRHPPQPHGNDIIEDVRNICSVLGCIETKQVSDAVKELTLILQRPSQNFHQNSETSKKGFIENVTSELSRSLHQL VDVYCSSFCTDFRPARAPGGVSRDHAGLHSHLSFTVCSLHNVPETWAHSYKAFSFSCWLTYAGKKLCQVKSCRSLPVTKSFSFSVNWNEIINFPLEIKSLPRESMLVIKLFGIDSATHSANLLAWTCL PLFPKEKSPLGSRLLSMTLQSEPPIEMMAPGVWDGSQPTPLTLQIDFPAATWEYVKPETEENRTDHQEPPRECLKHIARLSQKQPPLLLSVEKRRYLWFYRFYCNNENSSLPLVLGSAPGWDEGTVSE MHAVLRRWTFSHPLEALGLLTSRFPDQDIREVAVQQLDNFLTDELLDCLPQLVQAVKFEWSLESPLVELLLHRSLQSIRVAHRLFWLLRDAQGEDYFKSWYQELLAALQFCAGEALIEELSKEQKLVK LLGDIGEKVKSAGDAQRKDVLKKEIGSLEEFFKDIKTCHLPLNPALCVKGIDRDACSYFTSNALPLKITFINANPMGKNISVIFKAGDDLRQDMLVLQIIQVMDNVWLQEGLDMQMIIYGCLATGKAQ GFIEMVPDAVTLAKIHLHSGLIGPLKENTIKKWFSQHNHLKEDYEKALRNFFYSCAGWCVVTFILGVCDRHNDNIMLTKSGHMFHIDFGKFLGHAQTFGGIKRDRAPFIFTSEMEYFITEGGKNTQHF QDFVELCCRAYNIVRKHSQLLLSLLEMMLHAGLPELRGIEDLKYVHDNLRPQDTDLEATSHFTTKIKQSLECFPVKLNNLIHTLAQMPAFSLARPAPQTPPQECCVLNKTRTIQRVTILGFSKTHSNL YLIEVTRSDNRKNLAKKSFEQFYRLHSQIQKQFPLLTLPEFPHWWHLPFTDSHHERIRDLSHYVEQVLHGSYEVANSDCVLSFFLSEHIQQTLEDSPFVDPGDHSPDKSPQVQLLMTYEDTKLTILVK HLKNIHLPDGSAPSAHVEIYLLPHPSEVRRKKTKCVPKCTDPTYNEIVVYDDVSGLQGHVLMLIVKSKTVFVGAVNIQLCSVPLNEEKWYPLGNSII
hide sequence
Ensembl Acc Id:
ENSRNOP00000043855 ⟸ ENSRNOT00000041499
RefSeq Acc Id:
XP_038962876 ⟸ XM_039106948
- Peptide Label:
isoform X1
- UniProtKB:
O70173 (UniProtKB/Swiss-Prot), D3ZE56 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000071128 ⟸ ENSRNOT00000078963
RGD ID: 13693476
Promoter ID: EPDNEW_R3999
Type: initiation region
Name: Pik3c2g_1
Description: phosphatidylinositol-4-phosphate 3-kinase, catalytic subunittype 2 gamma
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 4 173,732,235 - 173,732,295 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2012-10-10
Pik3c2g
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
Pik3c2g
phosphoinositide-3-kinase, class 2, gamma polypeptide
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-09-09
Pik3c2g
phosphoinositide-3-kinase, class 2, gamma polypeptide
Pik3c2g
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2004-12-14
Pik3c2g
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide
Symbol and Name status set to approved
1299863
APPROVED
2002-08-07
Pik3c2g
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_expression
expression increases during liver regeneration with peak expression after the growth period
729517